SURGERY PARTNERS INC (SGRY)
US86881A1007 - Common Stock
Taking everything into account, SGRY scores 4 out of 10 in our fundamental rating. SGRY was compared to 118 industry peers in the Health Care Providers & Services industry. SGRY has a medium profitability rating, but doesn't score so well on its financial health evaluation. SGRY is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year SGRY was profitable.
SGRY had a positive operating cash flow in the past year.
In the past 5 years SGRY always reported negative net income.
Each year in the past 5 years SGRY had a positive operating cash flow.
1.2 Ratios
SGRY's Return On Assets of 0.01% is in line compared to the rest of the industry. SGRY outperforms 57.27% of its industry peers.
SGRY has a Return On Equity (0.03%) which is comparable to the rest of the industry.
With a decent Return On Invested Capital value of 5.35%, SGRY is doing good in the industry, outperforming 63.25% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for SGRY is below the industry average of 8.65%.
The last Return On Invested Capital (5.35%) for SGRY is above the 3 year average (4.74%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.01% | ||
| ROE | 0.03% | ||
| ROIC | 5.35% |
ROA(3y)-0.77%
ROA(5y)-1.48%
ROE(3y)-3.6%
ROE(5y)-11.01%
ROIC(3y)4.74%
ROIC(5y)4.35%
1.3 Margins
The Profit Margin of SGRY (0.02%) is comparable to the rest of the industry.
Looking at the Operating Margin, with a value of 15.65%, SGRY belongs to the top of the industry, outperforming 96.58% of the companies in the same industry.
In the last couple of years the Operating Margin of SGRY has remained more or less at the same level.
SGRY has a Gross Margin of 33.73%. This is in the better half of the industry: SGRY outperforms 61.54% of its industry peers.
SGRY's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 15.65% | ||
| PM (TTM) | 0.02% | ||
| GM | 33.73% |
OM growth 3Y14.22%
OM growth 5Y1.47%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.06%
GM growth 5Y-0.98%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), SGRY is destroying value.
The number of shares outstanding for SGRY has been increased compared to 1 year ago.
SGRY has more shares outstanding than it did 5 years ago.
SGRY has a worse debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of 0.97, we must say that SGRY is in the distress zone and has some risk of bankruptcy.
SGRY has a Altman-Z score of 0.97. This is comparable to the rest of the industry: SGRY outperforms 42.73% of its industry peers.
SGRY has a debt to FCF ratio of 16.45. This is a negative value and a sign of low solvency as SGRY would need 16.45 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 16.45, SGRY is in line with its industry, outperforming 55.56% of the companies in the same industry.
A Debt/Equity ratio of 1.42 is on the high side and indicates that SGRY has dependencies on debt financing.
SGRY's Debt to Equity ratio of 1.42 is on the low side compared to the rest of the industry. SGRY is outperformed by 64.10% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.42 | ||
| Debt/FCF | 16.45 | ||
| Altman-Z | 0.97 |
ROIC/WACC0.71
WACC7.55%
2.3 Liquidity
A Current Ratio of 1.71 indicates that SGRY should not have too much problems paying its short term obligations.
The Current ratio of SGRY (1.71) is better than 64.10% of its industry peers.
SGRY has a Quick Ratio of 1.56. This is a normal value and indicates that SGRY is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Quick ratio value of 1.56, SGRY is doing good in the industry, outperforming 67.52% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.71 | ||
| Quick Ratio | 1.56 |
3. Growth
3.1 Past
SGRY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 236.67%, which is quite impressive.
The Revenue has been growing slightly by 7.10% in the past year.
Measured over the past years, SGRY shows a quite strong growth in Revenue. The Revenue has been growing by 9.14% on average per year.
EPS 1Y (TTM)236.67%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q25%
Revenue 1Y (TTM)7.1%
Revenue growth 3Y13.83%
Revenue growth 5Y9.14%
Revenue growth Q2Q7.69%
3.2 Future
SGRY is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 19.36% yearly.
Based on estimates for the next years, SGRY will show a quite strong growth in Revenue. The Revenue will grow by 9.47% on average per year.
EPS Next Y2.58%
EPS Next 2Y14.83%
EPS Next 3Y18.47%
EPS Next 5Y19.36%
Revenue Next Year9.3%
Revenue Next 2Y9.06%
Revenue Next 3Y9.06%
Revenue Next 5Y9.47%
3.3 Evolution
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 26.69, which means the current valuation is very expensive for SGRY.
SGRY's Price/Earnings ratio is a bit cheaper when compared to the industry. SGRY is cheaper than 64.96% of the companies in the same industry.
When comparing the Price/Earnings ratio of SGRY to the average of the S&P500 Index (28.53), we can say SGRY is valued inline with the index average.
The Price/Forward Earnings ratio is 20.65, which indicates a rather expensive current valuation of SGRY.
Compared to the rest of the industry, the Price/Forward Earnings ratio of SGRY indicates a somewhat cheap valuation: SGRY is cheaper than 63.25% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 20.31. SGRY is around the same levels.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 26.69 | ||
| Fwd PE | 20.65 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, SGRY is valued a bit cheaper than 75.21% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, SGRY is valued a bit cheaper than the industry average as 77.78% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 19.64 | ||
| EV/EBITDA | 11.01 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as SGRY's earnings are expected to grow with 18.47% in the coming years.
PEG (NY)10.34
PEG (5Y)N/A
EPS Next 2Y14.83%
EPS Next 3Y18.47%
5. Dividend
5.1 Amount
No dividends for SGRY!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
SURGERY PARTNERS INC
NASDAQ:SGRY (5/14/2024, 7:00:32 PM)
Premarket: 27.26 +0.3 (+1.11%)26.96
+1.08 (+4.17%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap3.43B
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 26.69 | ||
| Fwd PE | 20.65 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)10.34
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.01% | ||
| ROE | 0.03% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 15.65% | ||
| PM (TTM) | 0.02% | ||
| GM | 33.73% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.4
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.42 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 1.71 | ||
| Quick Ratio | 1.56 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)236.67%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y2.58%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)7.1%
Revenue growth 3Y13.83%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y